103 related articles for article (PubMed ID: 32614144)
1. Hurthle cell carcinoma in childhood: A retrospective analysis of five cases and review of pediatric literature.
Zirilli G; Valenzise M; Dionigi G; Tuccari G; Romeo C; Campennì A; Corrias A; Tuli G; Ieni A; Pajno GB; Wasniewska M
Pediatr Blood Cancer; 2020 Sep; 67(9):e28300. PubMed ID: 32614144
[TBL] [Abstract][Full Text] [Related]
2. Pediatric differentiated thyroid carcinoma: The clinicopathological features and the coexistence of Hashimoto's thyroiditis.
Ren PY; Liu J; Xue S; Chen G
Asian J Surg; 2019 Jan; 42(1):112-119. PubMed ID: 29254871
[TBL] [Abstract][Full Text] [Related]
3. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area.
Hussein O; Abdelwahab K; Hamdy O; Awny S; Megahed NA; Hafez MT; Elalfi AF; Abdelaziz M; Gaballah K; Abdelkhalek M
J Egypt Natl Canc Inst; 2020 Jan; 32(1):7. PubMed ID: 32372240
[TBL] [Abstract][Full Text] [Related]
4. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
Lee J; Hasteh F
Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of papillary carcinoma and Hashimoto's thyroiditis.
Matesa-Anić D; Matesa N; Dabelić N; Kusić Z
Acta Clin Croat; 2009 Mar; 48(1):9-12. PubMed ID: 19623865
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
7. [Thyroid carcinoma and Hashimoto thyroiditis].
Intidhar Labidi S; Chaabouni AM; Kraiem T; Attia N; Gritli S; El May A; Ben Slimane F
Ann Otolaryngol Chir Cervicofac; 2006 Sep; 123(4):175-8. PubMed ID: 17088704
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
9. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
10. Hashimoto's Thyroiditis and Medullary Carcinoma of Thyroid.
Dasgupta S; Chakrabarti S; Mandal PK; Das S
JNMA J Nepal Med Assoc; 2014; 52(194):831-3. PubMed ID: 26905714
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents.
Iliadou PK; Effraimidis G; Konstantinos M; Grigorios P; Mitsakis P; Patakiouta F; Pazaitou-Panayiotou K
Eur J Endocrinol; 2015 Dec; 173(6):827-33. PubMed ID: 26369577
[TBL] [Abstract][Full Text] [Related]
12. Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.
Lee J; Yi S; Kang YE; Chang JY; Kim JT; Sul HJ; Kim JO; Kim JM; Kim J; Porcelli AM; Kim KS; Shong M
Oncotarget; 2016 Nov; 7(48):79117-79130. PubMed ID: 27816963
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.
Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K
Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180
[TBL] [Abstract][Full Text] [Related]
14. Differentiated thyroid carcinoma presentation may be more aggressive in children and adolescents than in young adults.
Zirilli G; Cannavò L; Vermiglio F; Violi MA; Luca F; Wasniewska M
Ital J Pediatr; 2018 Jan; 44(1):13. PubMed ID: 29343289
[TBL] [Abstract][Full Text] [Related]
15. Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.
Ghofrani M; Sosa JA; Ocal IT; Angeletti C
Acta Cytol; 2006; 50(5):560-2. PubMed ID: 17017447
[TBL] [Abstract][Full Text] [Related]
16. Hurthle cell carcinoma: a population-level analysis of 3311 patients.
Goffredo P; Roman SA; Sosa JA
Cancer; 2013 Feb; 119(3):504-11. PubMed ID: 22893587
[TBL] [Abstract][Full Text] [Related]
17. Management considerations in Hürthle cell carcinoma.
Azadian A; Rosen IB; Walfish PG; Asa SL
Surgery; 1995 Oct; 118(4):711-4; discussion 714-5. PubMed ID: 7570326
[TBL] [Abstract][Full Text] [Related]
18. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?
Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
Ann Surg Oncol; 2013 Sep; 20(9):2944-50. PubMed ID: 23616135
[TBL] [Abstract][Full Text] [Related]
19. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
20. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
